The study analyzed blood and urine samples from hospitalized patients between January 2021 and December 2023, finding the gene in 39% of blood cultures and 46% of urine cultures positive for carbapenamese-producing organisms, according to an Oct. 16 news release from the Infectious Disease Society of America.
The blaNDM gene enables bacteria to break down several classes of antibiotics, including carbapenems, penicillins and cephalosporins. The presence of blaNDM in blood samples was linked to a 48% mortality rate among affected patients, the release said.
Northwell researchers examined 71 CPO-positive blood cultures and 50 urine cultures from 10 hospitals, revealing an increase in blaNDM detection from January 2021 to December 2023.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
